These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33415792)
1. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study. Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792 [TBL] [Abstract][Full Text] [Related]
2. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI. Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768 [TBL] [Abstract][Full Text] [Related]
4. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379 [TBL] [Abstract][Full Text] [Related]
6. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Warbey VS; Ferner RE; Dunn JT; Calonje E; O'Doherty MJ Eur J Nucl Med Mol Imaging; 2009 May; 36(5):751-7. PubMed ID: 19142634 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1. Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778 [TBL] [Abstract][Full Text] [Related]
8. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1. Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062 [TBL] [Abstract][Full Text] [Related]
9. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1. Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076 [TBL] [Abstract][Full Text] [Related]
10. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095 [TBL] [Abstract][Full Text] [Related]
11. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors. Friedrich RE; Nörnberg LKN; Hagel C Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. Salamon J; Veldhoen S; Apostolova I; Bannas P; Yamamura J; Herrmann J; Friedrich RE; Adam G; Mautner VF; Derlin T Eur Radiol; 2014 Feb; 24(2):405-12. PubMed ID: 24097302 [TBL] [Abstract][Full Text] [Related]
13. The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1. Gesundheit B; Parkin P; Greenberg M; Baruchel S; Senger C; Kapelushnik J; Smith C; Klement GL J Pediatr Hematol Oncol; 2010 Oct; 32(7):548-53. PubMed ID: 20686424 [TBL] [Abstract][Full Text] [Related]
14. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. Friedrich RE; Kluwe L; Fünsterer C; Mautner VF Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085 [TBL] [Abstract][Full Text] [Related]
15. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment. Attia S; Guirguis M; Le LQ; Chhabra A Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998 [TBL] [Abstract][Full Text] [Related]
16. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases. McCarron KF; Goldblum JR Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181 [TBL] [Abstract][Full Text] [Related]
17. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. Salamon J; Mautner VF; Adam G; Derlin T Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104 [TBL] [Abstract][Full Text] [Related]
18. Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [ Azizi AA; Slavc I; Theisen BE; Rausch I; Weber M; Happak W; Aszmann O; Hojreh A; Peyrl A; Amann G; Benkoe TM; Wadsak W; Kasprian G; Staudenherz A; Hacker M; Traub-Weidinger T Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28771999 [TBL] [Abstract][Full Text] [Related]
19. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors. Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847 [TBL] [Abstract][Full Text] [Related]
20. Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath Tumors. Koike H; Nishida Y; Ito S; Shimoyama Y; Ikuta K; Urakawa H; Sakai T; Shimizu K; Ito K; Imagama S World Neurosurg; 2022 Jan; 157():e207-e214. PubMed ID: 34624521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]